Nintedanib Capsules, 100 mg and 150 mg
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
76282-787 -
Package NDC
76282-787-60 -
Application number
ANDA212609 -
SPL ID
e6cab487-5092-4b7b-a3c2-da94f6dc66c2 -
SPL set ID
60d8104e-cb6c-4f4f-8159-95ed57346ffa -
UNII
42F62RTZ4G -
RxCUI
1592742 -
RxCUI
1592750
What the source publishes
- Labeler
- EXELAN PHARMACEUTICALS INC.
- Active ingredients
- Nintedanib
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Nintedanib Capsules, 100 mg and 150 mg",
"splId": "e6cab487-5092-4b7b-a3c2-da94f6dc66c2",
"labels": [
{
"setId": "60d8104e-cb6c-4f4f-8159-95ed57346ffa",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=60d8104e-cb6c-4f4f-8159-95ed57346ffa",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=60d8104e-cb6c-4f4f-8159-95ed57346ffa"
}
],
"routes": [
"ORAL"
],
"labeler": "EXELAN PHARMACEUTICALS INC.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "60 CAPSULE in 1 BOTTLE (76282-787-60)",
"package_ndc": "76282-787-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20260507"
}
],
"productId": "76282-787_e6cab487-5092-4b7b-a3c2-da94f6dc66c2",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "76282-787",
"deaSchedule": null,
"genericName": "Nintedanib",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "NINTEDANIB ESYLATE",
"strength": "150 mg/1"
}
],
"applicationNumber": "ANDA212609",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260507",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0057200006189"
],
"unii": [
"42F62RTZ4G"
],
"rxcui": [
"1592742",
"1592750"
],
"spl_set_id": [
"60d8104e-cb6c-4f4f-8159-95ed57346ffa"
],
"manufacturer_name": [
"EXELAN PHARMACEUTICALS INC."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:76282-787_e6cab487-5092-4b7b-a3c2-da94f6dc66c2"